Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C
Authors
Keywords
-
Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 42, Issue 2, Pages 263-269
Publisher
Informa UK Limited
Online
2015-07-02
DOI
10.3109/03639045.2015.1047846
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier
- (2014) Abdul Wadood Khan et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone
- (2013) Shiuan-Pey Lin et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes
- (2013) Yoshiki Murakami et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transportin-vitroandin-vivo
- (2013) Iman S. Ahmed et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach
- (2013) Qin Li et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- In vitro–in vivoextrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications
- (2013) Hyun-Jong Cho et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacsin vitro
- (2013) M. Surya Sandeep et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Effect of Honokiol on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
- (2013) Hyeon-Uk Jeong et al. MOLECULES
- Biopharmaceutical characterization of decursin and their derivatives for drug discovery
- (2012) Bimit Mahat et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates
- (2012) Kai Zhao et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats
- (2012) Yan-Hui Zhang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes
- (2012) John H.K. Yeung et al. PHYTOMEDICINE
- Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily
- (2012) Seung Yon Han et al. XENOBIOTICA
- Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9
- (2012) Liangliang Zhu et al. XENOBIOTICA
- Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
- (2011) X.-W. Chen et al. CURRENT MEDICINAL CHEMISTRY
- Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity
- (2011) Siamak Cyrus Khojasteh et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Pharmacokinetics, Bioavailability, and Tissue Distribution of Magnolol Following Single and Repeated Dosing of Magnolol to Rats
- (2011) Shiuan-Pey Lin et al. PLANTA MEDICA
- An Epidemiological Study of Concomitant Use of Chinese Medicine and Antipsychotics in Schizophrenic Patients: Implication for Herb-Drug Interaction
- (2011) Zhang-Jin Zhang et al. PLoS One
- Effects of herbal products on the metabolism and transport of anticancer agents
- (2010) Shu-Ming He et al. Expert Opinion on Drug Metabolism & Toxicology
- Simultaneous HPLC determination of tolbutamide, phenacetin and their metabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate
- (2010) Jan Juřica et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Important drug–nutrient interactions
- (2010) Pamela Mason PROCEEDINGS OF THE NUTRITION SOCIETY
- Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol
- (2010) In-Soo Yoon et al. XENOBIOTICA
- Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations
- (2009) Francesca Borrelli et al. AAPS Journal
- Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats
- (2009) Yung-Hsiang Chen et al. ARCHIVES OF PHARMACAL RESEARCH
- Clinically based evidence of drug–herb interactions: a systematic review
- (2009) Deborah A Kennedy et al. Expert Opinion On Drug Safety
- Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells
- (2009) Dae-Hee Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- High-Affinity Interaction of Sartans with H+/Peptide Transporters
- (2008) I. Knutter et al. DRUG METABOLISM AND DISPOSITION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started